For Patients

LEAFLET

What is the PERMIT project? Which PERMIT recommendations are most relevant for patients? Why are these important? All of these questions are addressed in this short leaflet, developed in collaboration with the European Patients' Forum (EPF). 

Download here.

 

LAY SUMMARY - TRANSLATIONAL METHODS 

The translational stage is essential in the personalised medicine research pipeline. A review of the existing literature was conducted to map the methods that are currently used during this stage and to identify the main gaps and challenges that could be addressed with targeted recommendations.

Read more about the findings here. 

 

LAY SUMMARY - CLINICAL TRIALS IN PERSONALISED MEDICINE

Evaluating therapeutic solutions through clinical trials is essential, before integrating them into routine care. A review of the literature on the methods and clinical trial designs used in personalised medicine was conducted to better understand the most commonly used designs and to identify gaps and challenges that could be addressed with targeted recommendations. 

Learn more about the findings here.